NasdaqCM - Nasdaq Real Time Price USD
CERo Therapeutics Holdings, Inc. (CERO)
0.4545
+0.0265
+(6.19%)
At close: June 6 at 4:00:01 PM EDT
0.3720
-0.08
(-18.15%)
Pre-Market: 4:32:00 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
--
-5,789.9870
-11,709.3110
-10,094.3800
Investing Cash Flow
--
--
-694.2320
-612.5660
Financing Cash Flow
--
571.6780
5.6250
60.2550
End Cash Position
--
1,601.2550
6,819.5640
19,217.4820
Capital Expenditure
--
--
-694.2320
-612.5660
Issuance of Capital Stock
--
0
--
--
Issuance of Debt
--
605.2300
--
--
Free Cash Flow
--
-5,789.9870
-12,403.5430
-10,706.9460
12/31/2021 - 11/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
PCSA Processa Pharmaceuticals, Inc.
0.3006
+3.55%
SILO Silo Pharma, Inc.
0.5811
-9.20%
GLYC GlycoMimetics, Inc.
0.1938
-2.42%
TOVX Theriva Biologics, Inc.
0.4700
-0.21%
KAPA Kairos Pharma, Ltd.
0.4730
-5.87%
ADTX Aditxt, Inc.
1.5400
+6.94%
PSTV Plus Therapeutics, Inc.
0.3255
+2.04%
REVB Revelation Biosciences, Inc.
0.8594
+5.45%
PHIO Phio Pharmaceuticals Corp.
2.9600
+20.33%